LEADER 03850nam  22006135  450 
001 9910300075503321
005 20251117071629.0
010   $a1-4471-5475-4
024 7 $a10.1007/978-1-4471-5475-4
035   $a(CKB)3710000000073897
035   $a(EBL)1592861
035   $a(SSID)ssj0001067201
035   $a(PQKBManifestationID)11616914
035   $a(PQKBTitleCode)TC0001067201
035   $a(PQKBWorkID)11079531
035   $a(PQKB)11037798
035   $a(MiAaPQ)EBC1592861
035   $a(DE-He213)978-1-4471-5475-4
035   $a(PPN)176096957
035   $a(EXLCZ)993710000000073897
100   $a20131125d2014      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAtrial Fibrillation Therapy /$fedited by Gheorghe-Andrei Dan, Antoni Bayés de Luna, John Camm
205   $a1st ed. 2014.
210  1$aLondon :$cSpringer London :$cImprint: Springer,$d2014.
215   $a1 online resource (200 p.)
225 1 $aCurrent Cardiovascular Therapy
300   $aDescription based upon print version of record.
311 08$a1-4471-5474-6 
320   $aIncludes bibliographical references and index.
327   $aEpidemiology, burden and unmet needs in atrial fibrillation -- Inside Molecular Mechanisms and pharmacological Targets of Atrial Fibrillation -- Novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation -- Upstream therapy in the treatment of atrial fibrillation -- Drug therapy for rhythm and rate control in Atrial Fibrillation -- Changing the paradigm to understand and manage Atrial Fibrillation -- Guidelines and current recommendations in Atrial Fibrillation.
330   $aThis book presents the current evidence and practice in the pharmacological treatment of atrial fibrillation (AF). AF management has changed significantly in recent years as a new era has begun for the prevention of stroke, one of the most devastating complications of AF. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge and the enormous amount of research is revealing new treatment opportunities at a dizzying pace. While new classes of antithrombotic drugs for AF treatment are still in their infancy, recent research is revealing how these can be applied with optimal efficacy. Atrial Fibrillation Therapy includes practical information for readers on applying the guidelines developed as a result of the increased pharmacotherapeutic understanding. This book also guides trainees, recertifying physicians, and practicing physicians in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply the new diagnostic tools for selecting the best treatment options for AF patients. Discusses new diagnostic tools for selecting therapies for AF patients Presents recent research in a highly practical, easy reference style Emphasis on a just-the-facts approach to the treatment options in AF.
410  0$aCurrent Cardiovascular Therapy
606   $aCardiology
606   $aChemotherapy
606   $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037
606   $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000
615  0$aCardiology.
615  0$aChemotherapy.
615 14$aCardiology.
615 24$aPharmacotherapy.
676   $a615.1
676   $a616.1/28
702   $aDan$b Gheorghe-Andrei$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aBayés de Luna$b Antoni$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aCamm$b John$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300075503321
996   $aAtrial Fibrillation Therapy$91521947
997   $aUNINA